Association of CDKN2A/B and MTAP deletions in adult-type diffuse gliomas
Journal of Neuropathology & Experimental Neurology · 2026
DOI: 10.1093/jnen/nlag007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2026. Verfasst von Blake A Ebner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota USA. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Purine-Nucleoside Phosphorylase, Gene Deletion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In adult-type diffuse gliomas CDKN2A and/or CDKN2B (CDKN2A/B) deletions often co-occur with deletion of MTAP, suggesting that MTAP immunohistochemistry (IHC) may be a surrogate marker of CDKN2A/B status. However, the association between CDKN2A/B and MTAP deletion at the genomic level remains unknown. We assessed CDKN2A/B and MTAP deletions by chromosomal microarray in 333 adult-type diffuse gliomas and performed MTAP IHC on a subset (n = 63). CDKN2A/B and MTAP deletions were detected in 216 and 215 cases, respectively, and were concurrent in 99.5% (215/216). While most tumors with CDKN2A/B homozygous deletion (n = 148) showed concurrent MTAP homozygous deletion (108/148; 73.0%), a subset harbored MTAP heterozygous deletion (39/148; 26.4%). By analyzing the size of the chromosomal alterations, we demonstrate that initial large chromosomal 9p losses result in concurrent heterozygous deletion of CDKN2A/B and MTAP whereas smaller “second hit” deletions leading to homozygous CDKN2A/B deletion do not always encompass the MTAP locus. Discordant CDKN2A/B and MTAP tumors affect the association between MTAP IHC and copy number status of MTAP and CDKN2A/B. These findings suggest that adult-type diffuse gliomas, regardless of IDH status, follow a stereotypic pathway involving concurrent CDKN2A/B and MTAP heterozygous deletion but may diverge for CDKN2A/B and MTAP homozygous deletion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota USA.
ORCID-Profile: Blake A Ebner, Cristiane M Ida, Robert B Jenkins, Aditya Raghunathan
Zitieren
APA
Ebner, B. A., Ida, C. M., Kollmeyer, T. M., Jenkins, R. B., Zepeda Mendoza, C. J., Giannini, C., Trejo-Lopez, J. A., & Raghunathan, A. (2026). Association of CDKN2A/B and MTAP deletions in adult-type diffuse gliomas. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlag007
Vancouver
Ebner BA, Ida CM, Kollmeyer TM, Jenkins RB, Zepeda Mendoza CJ, Giannini C, et al. Association of CDKN2A/B and MTAP deletions in adult-type diffuse gliomas. Journal of Neuropathology & Experimental Neurology. 2026. doi:10.1093/jnen/nlag007
BibTeX
@article{Ebner2026,
author = {Ebner, Blake A and Ida, Cristiane M and Kollmeyer, Thomas M and Jenkins, Robert B and Zepeda Mendoza, Cinthya J and Giannini, Caterina and Trejo-Lopez, Jorge A and Raghunathan, Aditya},
title = {Association of CDKN2A/B and MTAP deletions in adult-type diffuse gliomas},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2026},
doi = {10.1093/jnen/nlag007}
}
EUVIMED